DGX
35
2
SYF
74
5
C
82
3
MCK
67
3
NKE
28
-12
HSY
43
2
BIIB
50
4
NWS
60
2
GOOG
57
2
HBAN
82
3
PCG
74
2
MLM
67
4
VRTX
53
5
IP
28
-3
WFC
74
5
APH
56
7
AMG
77
3
QCOM
45
2
MAT
50
-5
PYPL
52
2
DGX
35
2
SYF
74
5
C
82
3
MCK
67
3
NKE
28
-12
HSY
43
2
BIIB
50
4
NWS
60
2
GOOG
57
2
HBAN
82
3
PCG
74
2
MLM
67
4
VRTX
53
5
IP
28
-3
WFC
74
5
APH
56
7
AMG
77
3
QCOM
45
2
MAT
50
-5
PYPL
52
2
Financhill
Back

BNY Mellon Ultra Short Income ETF Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison

Sell
45

BKUI
BNY Mellon Ultra Short Income ETF

Last Price:
$49.88
Seasonality Move:
0.14%
Buy
72

RIGL
Rigel Pharmaceuticals, Inc.

Last Price:
$41.63
Seasonality Move:
-1.35%
Sell
45
BNY Mellon Ultra Short Income ETF (BKUI) is a Sell

Is BNY Mellon Ultra Short Income ETF a Buy, Sell or Hold?

  • The current BNY Mellon Ultra Short Income ETF [BKUI] share price is $49.89. The Score for BKUI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BKUI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL) is a Buy

Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.59. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BKUI Stock Price Chart

What is BNY Mellon Ultra Short Income ETF's stock price today?

  • The BNY Mellon Ultra Short Income ETF share price today is $49.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BKUI is experiencing buying pressure, which is a positive indicator for future bullish movement.

RIGL Stock Price Chart

What is Rigel Pharmaceuticals, Inc.'s stock price today?

  • The Rigel Pharmaceuticals, Inc. share price today is $41.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.

BKUI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 61.1 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.8 - 49.88) Buy
Bollinger Bands (100): (49.78 - 49.9) Buy

RIGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.85 Buy
Relative Strength Index (14 RSI): 48.4 Sell
Chaikin Money Flow: -1420728 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.45 - 47.99) Sell
Bollinger Bands (100): (29.17 - 43.09) Buy

BKUI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.85 Buy
20-day SMA: 49.84 Buy
50-day SMA: 49.85 Buy
200-day SMA: 49.79 Buy
8-day EMA: 49.85 Buy
20-day EMA: 49.84 Buy
50-day EMA: 49.84 Buy
200-day EMA: 49.8 Buy

RIGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.73 Sell
20-day SMA: 45.09 Sell
50-day SMA: 38.13 Buy
200-day SMA: 27.66 Buy
8-day EMA: 22.1 Buy
20-day EMA: 10.83 Buy
50-day EMA: 4.72 Buy
200-day EMA: 1.23 Buy

BNY Mellon Ultra Short Income ETF Earnings Growth & BKUI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.

BNY Mellon Ultra Short Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rigel Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):